Clinical significance of TILs subtypes in non-small cell lung cancer

被引：0
|
作者：
Schalper, Kurt A.
Brown, Jason
McLaughlin, Joseph Francis
Herbst, Roy S.
Rimm, David L.
机构：
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[2] Yale Univ, Dept Med Oncol, New Haven, CT USA
[3] Yale Canc Ctr, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8082
引用
收藏
页数：1
相关论文
共 50 条
  • [41] EXPRESSION OF HEPARANASE AND ITS CLINICAL SIGNIFICANCE IN HUMAN NON-SMALL CELL LUNG CANCER
    韩昱晨
    李姝玉
    于敏
    谷雨妹
    张四洋
    IRIS Pecker
    王恩华
    邱雪杉
    Chinese Journal of Cancer Research, 2005, (03) : 207 - 212
  • [42] Clinical significance of heparanase activity in primary resected non-small cell lung cancer
    Takahashi, H
    Ebihara, S
    Okazaki, T
    Suzuki, S
    Asada, M
    Kubo, H
    Sasaki, H
    LUNG CANCER, 2004, 45 (02) : 207 - 214
  • [43] Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer
    Wakabayashi, Yu
    Masuda, Takeshi
    Fujitaka, Kazunori
    Nakashima, Taku
    Okumoto, Joe
    Shimoji, Kiyofumi
    Nishimura, Yoshifumi
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Miyamoto, Shintaro
    Iwamoto, Hiroshi
    Ohshimo, Shinichiro
    Hamada, Hironobu
    Hattori, Noboru
    CANCER SCIENCE, 2021, 112 (01) : 369 - 379
  • [44] Clinical significance of ALKBH4 expression in non-small cell lung cancer
    Aoki, Masaya
    Ueda, Kazuhiro
    Kamimura, Go
    Iwamoto, Yoshiyuki
    Ikehata, Mizuki
    Tabata, Keisuke
    Sakagami, Yuri
    Morizono, Shoichiro
    Tokunaga, Takuya
    Umehara, Tadashi
    Harada-Takeda, Aya
    Maeda, Koki
    Nagata, Toshiyuki
    Kariatsumari, Kota
    Furukawa, Tatsuhiko
    Tsujikawa, Kazutake
    Sato, Masami
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (07) : 2040 - 2049
  • [45] Expression of β-catenin and OPG in human non-small cell lung cancer and their clinical significance
    Li, Zhen-Zhen
    Zhang, Shi-Min
    Yang, Chun-Xu
    Sun, Shao-Xing
    Yang, Jie
    Tian, Xiao-Li
    Xiong, Fei
    Wang, Sheng
    Xie, Cong-Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7244 - 7254
  • [46] Clinical Significance of BRAF Gene Mutations in Patients with Non-small Cell Lung Cancer
    Kobayashi, Masashi
    Sonobe, Makoto
    Takahashi, Tsuyoshi
    Yoshizawa, Akihiko
    Ishikawa, Masashi
    Kikuchi, Ryutaro
    Okubo, Kenichi
    Huang, Cheng-Long
    Date, Hiroshi
    ANTICANCER RESEARCH, 2011, 31 (12) : 4619 - 4623
  • [47] Clinical significance of plasma free DNA in patients with non-small cell lung cancer
    Ma, Lanxiang
    Du, Jie
    Sui, Yongjie
    Wang, Shuili
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (11) : 5593 - 5600
  • [48] Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer
    Judd, Julia
    Karim, Nagla Abdel
    Khan, Hina
    Naqash, Abdul Rafeh
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes Jr, Gilberto de Lima
    Spira, Alexander I.
    Korn, W. Michael
    Kim, Edward S.
    Liu, Stephen V.
    Borghaei, Hossein
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2577 - 2584
  • [49] Detecting subtypes of non-small cell lung cancer by electronic nose
    Kort, Sharina
    Tiggeloven, Mayke
    Brusse-Keizer, Marjolein
    Schouwink, Hugo
    De Jongh, Frans
    Citgez, Emanuel
    Gerritsen, Jan Willem
    Van der Palen, Job
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [50] Lung Resistance Protein and Multidrug Resistance Protein in Non-small Cell Lung Cancer and Their Clinical Significance
    Chen, Z. J.
    Le, H. B.
    Zhang, Y. K.
    Qian, L. Y.
    Sekhar, K. Raja
    Li, W. D.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (05) : 1693 - 1700
12345